PRELIMINARY PROGRAM
Thursday, 10th September 2026
Workshop: Phosphoproteomics & Pathways Mapping
09:00-09:15 Welcome & Introduction
09:15-10:45 Module 1: Phosphoproteomics workflow & dataset exploration
10:45-11:15 Coffee-break / Networking
11:15-12:45 Module 2: Live-cell imaging (pre-recorded movies, quantify dynamics)
Conference sessions
13:00-14:00 Registration
14:00-14:15 Welcome session
14:15-15:30 Session 1 Signalling in health and disease
To be annouced
15:30-16:30 Coffee-break and poster session
16:30-17:10 Sandra Rebelo, iBiMED
To be announced
17:10-17:50 Short talks
18:00 Social activity, networking and dinner
Friday, 11th September 2026
Conference sessions
08:30-09:30 Registration
09:30-10:50 Session 2 Diagnostic and therapeutic targets
Modeling Parkinson's disease to uncover new therapeutic targets for non-motor symptoms and complications. | Gilberto Fisone, Karolinska Institutet
PSGL-1 expression and activation in B-cell lymphoma: a marker for immunotherapy | Nuno Santos, i3S
10:50-11:25 Coffee-break and poster session
11:25-12:05 Short talks
12:05-13:00 Poster session
13:00-14:30 Lunch
14:30-16:00 Session 3 Innovative technologies in signalling
From chemical probes to drug discovery | Edward Tate, Imperial College London
To be announced
16:00-16:30 Coffee-break
16:30-17:10 New therapeutic strategies in T-cell Acute Lymphoblastic Leukemia | Rita Fragoso, iMM
Peroxisomal antiviral signalling as a platform for the development of novel broad-spectrum host‑directed antiviral therapies | Daniela Ribeiro, iBiMED
17:10-17:50 Short talks
18:00 Closing session and awards
Funding
iBiMED
UID/04501/2025
